Europe Active Pharmaceutical Ingredient Sales Market Report 2020

Market: Chemicals and Materials

, 122 pages report, published by QYResearch

Report ThumbnailJuly-2016
This report studies sales (consumption) of Active Pharmaceutical Ingredient in Europe market, especially in Germany, UK, France, Italy, Spain and Russia,focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Aurobindo Pharma
Novartis International
Teva Pharmaceutical Industries
Albemarle
Sun Pharmaceutical Industries
Mylan
Dr. Reddy’s Laboratories
Sigma-Aldrich
Allergan
Boehringer Ingelheim
...

Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Active Pharmaceutical Ingredient in these regions, from 2011 to 2020 (forecast), like
Germany
France
UK
Italy
Spain
Russia

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Innovative APIS Segment
Generic APIS Segment

Split by applications, this report focuses on sales, market share and growth rate of Active Pharmaceutical Ingredient in each application, can be divided into
Chemical
Deodorant
Dailylife

  • List of Tables and Figures
  • Figure Picture of Active Pharmaceutical Ingredient
  • Table Classification of Active Pharmaceutical Ingredient
  • Figure Europe Sales Market Share of Active Pharmaceutical Ingredient by Types in 2016
  • Figure Innovative APIS Segment Picture
  • Figure Generic APIS Segment Picture
  • Table Applications of Active Pharmaceutical Ingredient
  • Figure Europe Sales Market Share of Active Pharmaceutical Ingredient by Applications in 2016
  • Figure Chemical Examples
  • Figure Deodorant Examples
  • Figure Dailylife Examples
  • Figure Germany Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • Figure France Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • Figure UK Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • Figure Italy Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • Figure Spain Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • Figure Russia Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • Table Europe Active Pharmaceutical Ingredient Sales, Revenue and Price (2011-2020)
  • Figure Europe Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)
  • Figure Europe Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • Table Europe Active Pharmaceutical Ingredient Sales of Key Manufacturers (2015 and 2016)
  • Table Europe Active Pharmaceutical Ingredient Sales Share by Manufacturers (2015 and 2016)
  • Figure 2015 Active Pharmaceutical Ingredient Sales Share by Manufacturers
  • Figure 2016 Active Pharmaceutical Ingredient Sales Share by Manufacturers
  • Table Europe Active Pharmaceutical Ingredient Revenue by Manufacturers (2015 and 2016)
  • Table Europe Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015 and 2016)
  • Table 2015 Europe Active Pharmaceutical Ingredient Revenue Share by Manufacturers
  • Table 2016 Europe Active Pharmaceutical Ingredient Revenue Share by Manufacturers
  • Table Europe Active Pharmaceutical Ingredient Sales and Market Share by Type (2011-2020)
  • Table Europe Active Pharmaceutical Ingredient Sales Share by Type (2011-2020)
  • Figure Sales Market Share of Active Pharmaceutical Ingredient by Type (2011-2020)
  • Figure Europe Active Pharmaceutical Ingredient Sales Growth Rate by Type (2011-2020)
  • Table Europe Active Pharmaceutical Ingredient Revenue and Market Share by Type (2011-2020)
  • Table Europe Active Pharmaceutical Ingredient Revenue Share by Type (2011-2020)
  • Figure Revenue Market Share of Active Pharmaceutical Ingredient by Type (2011-2020)
  • Figure Europe Active Pharmaceutical Ingredient Revenue Growth Rate by Type (2011-2020)
  • Table Europe Active Pharmaceutical Ingredient Sales and Market Share by Regions (2011-2020)
  • Table Europe Active Pharmaceutical Ingredient Sales Share by Regions (2011-2020)
  • Figure Sales Market Share of Active Pharmaceutical Ingredient by Regions (2011-2020)
  • Figure Europe Active Pharmaceutical Ingredient Sales Growth Rate by Regions (2011-2020)
  • Table Europe Active Pharmaceutical Ingredient Revenue and Market Share by Regions (2011-2020)
  • Table Europe Active Pharmaceutical Ingredient Revenue Share by Regions (2011-2020)
  • Figure Revenue Market Share of Active Pharmaceutical Ingredient by Regions (2011-2020)
  • Figure Europe Active Pharmaceutical Ingredient Revenue Growth Rate by Regions (2011-2020)
  • Table Europe Active Pharmaceutical Ingredient Sales and Market Share by Application (2011-2020)
  • Table Europe Active Pharmaceutical Ingredient Sales Share by Application (2011-2020)
  • Figure Sales Market Share of Active Pharmaceutical Ingredient by Application (2011-2020)
  • Figure Europe Active Pharmaceutical Ingredient Sales Growth Rate by Application (2011-2020)
  • Figure Germany Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)
  • Figure Germany Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • Figure Germany Active Pharmaceutical Ingredient Sales Price Trend (2011-2020)
  • Table Germany Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)
  • Table Germany Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)
  • Table Germany Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)
  • Table Germany Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)
  • Table Germany Active Pharmaceutical Ingredient Sales by Applications (2015 and 2016)
  • Table Germany Active Pharmaceutical Ingredient Market Share by Applications (2015 and 2016)
  • Figure UK Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)
  • Figure UK Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • Figure UK Active Pharmaceutical Ingredient Sales Price Trend (2011-2020)
  • Table UK Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)
  • Table UK Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)
  • Table UK Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)
  • Table UK Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)
  • Table UK Active Pharmaceutical Ingredient Sales by Applications (2015 and 2016)
  • Table UK Active Pharmaceutical Ingredient Market Share by Applications (2015 and 2016)
  • Figure France Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)
  • Figure France Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • Figure France Active Pharmaceutical Ingredient Sales Price Trend (2011-2020)
  • Table France Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)
  • Table France Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)
  • Table France Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)
  • Table France Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)
  • Table France Active Pharmaceutical Ingredient Sales by Applications (2015 and 2016)
  • Table France Active Pharmaceutical Ingredient Market Share by Applications (2015 and 2016)
  • Figure Italy Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)
  • Figure Italy Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • Figure Italy Active Pharmaceutical Ingredient Sales Price Trend (2011-2020)
  • Table Italy Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)
  • Table Italy Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)
  • Table Italy Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)
  • Table Italy Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)
  • Table Italy Active Pharmaceutical Ingredient Sales by Applications (2015 and 2016)
  • Table Italy Active Pharmaceutical Ingredient Market Share by Applications (2015 and 2016)
  • Figure Russia Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)
  • Figure Russia Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • Figure Russia Active Pharmaceutical Ingredient Sales Price Trend (2011-2020)
  • Table Russia Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)
  • Table Russia Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)
  • Table Russia Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)
  • Table Russia Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)
  • Table Russia Active Pharmaceutical Ingredient Sales by Applications (2015 and 2016)
  • Table Russia Active Pharmaceutical Ingredient Market Share by Applications (2015 and 2016)
  • Figure Spain Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)
  • Figure Spain Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • Figure Spain Active Pharmaceutical Ingredient Sales Price Trend (2011-2020)
  • Table Spain Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)
  • Table Spain Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)
  • Table Spain Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)
  • Table Spain Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)
  • Table Spain Active Pharmaceutical Ingredient Sales by Applications (2015 and 2016)
  • Table Spain Active Pharmaceutical Ingredient Market Share by Applications (2015 and 2016)
  • Table Aurobindo Pharma Basic Information List
  • Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Aurobindo Pharma (2015 and 2016)
  • Table Novartis International Basic Information List
  • Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Novartis International (2015 and 2016)
  • Table Teva Pharmaceutical Industries Basic Information List
  • Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Teva Pharmaceutical Industries (2015 and 2016)
  • Table Albemarle Basic Information List
  • Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Albemarle (2015 and 2016)
  • Table Sun Pharmaceutical Industries Basic Information List
  • Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Sun Pharmaceutical Industries (2015 and 2016)
  • Table Mylan Basic Information List
  • Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Mylan (2015 and 2016)
  • Table Dr. Reddy’s Laboratories Basic Information List
  • Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Dr. Reddy’s Laboratories (2015 and 2016)
  • Table Sigma-Aldrich Basic Information List
  • Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Sigma-Aldrich (2015 and 2016)
  • Table Allergan Basic Information List
  • Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Allergan (2015 and 2016)
  • Table Boehringer Ingelheim Basic Information List
  • Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)
  • ...
  • Table Mylan Basic Information List
  • Table of Contents
  • 1 Active Pharmaceutical Ingredient Overview
  • 1.1 Product Overview and Scope of Active Pharmaceutical Ingredient
  • 1.2 Classification of Active Pharmaceutical Ingredient
  • 1.2.1 Innovative APIS Segment
  • 1.2.2 Generic APIS Segment
  • 1.3 Applications of Active Pharmaceutical Ingredient
  • 1.3.1 Chemical
  • 1.3.2 Deodorant
  • 1.3.3 Dailylife
  • 1.4 Active Pharmaceutical Ingredient Market by Regions
  • 1.4.1 Germany Status and Prospect (2011-2020)
  • 1.4.2 France Status and Prospect (2011-2020)
  • 1.4.3 UK Status and Prospect (2011-2020)
  • 1.4.4 Italy Status and Prospect (2011-2020)
  • 1.4.5 Spain Status and Prospect (2011-2020)
  • 1.4.6 Russia Status and Prospect (2011-2020)
  • 1.5 Europe Market Size (Value and Volume) of Active Pharmaceutical Ingredient (2011-2020)
  • 1.5.1 Europe Active Pharmaceutical Ingredient Sales, Revenue and Price (2011-2020)
  • 1.5.2 Europe Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)
  • 1.5.3 Europe Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • 2 Europe Active Pharmaceutical Ingredient by Manufacturers, Type and Application
  • 2.1 Europe Active Pharmaceutical Ingredient Market Competition by Manufacturers
  • 2.1.1 Europe Active Pharmaceutical Ingredient Sales and Market Share of Key Manufacturers (2015 and 2016)
  • 2.1.2 Europe Active Pharmaceutical Ingredient Revenue and Share by Manufacturers (2015 and 2016)
  • 2.2 Europe Active Pharmaceutical Ingredient (Volume and Value) by Type
  • 2.2.1 Europe Active Pharmaceutical Ingredient Sales and Market Share by Type (2011-2020)
  • 2.2.2 Europe Active Pharmaceutical Ingredient Revenue and Market Share by Type (2011-2020)
  • 2.3 Europe Active Pharmaceutical Ingredient (Volume and Value) by Regions
  • 2.3.1 Europe Active Pharmaceutical Ingredient Sales and Market Share by Regions (2011-2020)
  • 2.3.2 Europe Active Pharmaceutical Ingredient Revenue and Market Share by Regions (2011-2020)
  • 2.4 Europe Active Pharmaceutical Ingredient (Volume) by Application
  • 3 Germany Active Pharmaceutical Ingredient (Volume, Value and Sales Price)
  • 3.1 Germany Active Pharmaceutical Ingredient Sales and Value (2011-2020)
  • 3.1.1 Germany Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)
  • 3.1.2 Germany Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • 3.1.3 Germany Active Pharmaceutical Ingredient Sales Price Trend (2011-2020)
  • 3.2 Germany Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
  • 3.3 Germany Active Pharmaceutical Ingredient Sales and Market Share by Type
  • 3.4 Germany Active Pharmaceutical Ingredient Sales and Market Share by Applications
  • 4 UK Active Pharmaceutical Ingredient (Volume, Value and Sales Price)
  • 4.1 UK Active Pharmaceutical Ingredient Sales and Value (2011-2020)
  • 4.1.1 UK Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)
  • 4.1.2 UK Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • 4.1.3 UK Active Pharmaceutical Ingredient Sales Price Trend (2011-2020)
  • 4.2 UK Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
  • 4.3 UK Active Pharmaceutical Ingredient Sales and Market Share by Type
  • 4.4 UK Active Pharmaceutical Ingredient Sales and Market Share by Applications
  • 5 France Active Pharmaceutical Ingredient (Volume, Value and Sales Price)
  • 5.1 France Active Pharmaceutical Ingredient Sales and Value (2011-2020)
  • 5.1.1 France Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)
  • 5.1.2 France Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • 5.1.3 France Active Pharmaceutical Ingredient Sales Price Trend (2011-2020)
  • 5.2 France Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
  • 5.3 France Active Pharmaceutical Ingredient Sales and Market Share by Type
  • 5.4 France Active Pharmaceutical Ingredient Sales and Market Share by Applications
  • 6 Italy Active Pharmaceutical Ingredient (Volume, Value and Sales Price)
  • 6.1 Italy Active Pharmaceutical Ingredient Sales and Value (2011-2020)
  • 6.1.1 Italy Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)
  • 6.1.2 Italy Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • 6.1.3 Italy Active Pharmaceutical Ingredient Sales Price Trend (2011-2020)
  • 6.2 Italy Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
  • 6.3 Italy Active Pharmaceutical Ingredient Sales and Market Share by Type
  • 6.4 Italy Active Pharmaceutical Ingredient Sales and Market Share by Applications
  • 7 Russia Active Pharmaceutical Ingredient (Volume, Value and Sales Price)
  • 7.1 Russia Active Pharmaceutical Ingredient Sales and Value (2011-2020)
  • 7.1.1 Russia Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)
  • 7.1.2 Russia Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • 7.1.3 Russia Active Pharmaceutical Ingredient Sales Price Trend (2011-2020)
  • 7.2 Russia Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
  • 7.3 Russia Active Pharmaceutical Ingredient Sales and Market Share by Type
  • 7.4 Russia Active Pharmaceutical Ingredient Sales and Market Share by Applications
  • 8 Spain Active Pharmaceutical Ingredient (Volume, Value and Sales Price)
  • 8.1 Spain Active Pharmaceutical Ingredient Sales and Value (2011-2020)
  • 8.1.1 Spain Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)
  • 8.1.2 Spain Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)
  • 8.1.3 Spain Active Pharmaceutical Ingredient Sales Price Trend (2011-2020)
  • 8.2 Spain Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
  • 8.3 Spain Active Pharmaceutical Ingredient Sales and Market Share by Type
  • 8.4 Spain Active Pharmaceutical Ingredient Sales and Market Share by Applications
  • 9 Europe Active Pharmaceutical Ingredient Manufacturers Analysis
  • 9.1 Aurobindo Pharma
  • 9.1.1 Company Basic Information,Manufacturing Base and Competitors
  • 9.1.2 Active Pharmaceutical Ingredient Product Type and Technology
  • 9.1.2.1 Type I
  • 9.1.2.2 Type II
  • 9.1.3 Active Pharmaceutical Ingredient Sales, Revenue, Price of Aurobindo Pharma (2015 and 2016)
  • 9.2 Novartis International
  • 9.2.1 Company Basic Information,Manufacturing Base and Competitors
  • 9.2.2 Active Pharmaceutical Ingredient Product Type and Technology
  • 9.2.2.1 Type I
  • 9.2.2.2 Type II
  • 9.2.3 Active Pharmaceutical Ingredient Sales, Revenue, Price of Novartis International (2015 and 2016)
  • 9.3 Teva Pharmaceutical Industries
  • 9.3.1 Company Basic Information,Manufacturing Base and Competitors
  • 9.3.2 Active Pharmaceutical Ingredient Product Type and Technology
  • 9.3.2.1 Type I
  • 9.3.2.2 Type II
  • 9.3.3 Active Pharmaceutical Ingredient Sales, Revenue, Price of Teva Pharmaceutical Industries (2015 and 2016)
  • 9.4 Albemarle
  • 9.4.1 Company Basic Information,Manufacturing Base and Competitors
  • 9.4.2 Active Pharmaceutical Ingredient Product Type and Technology
  • 9.4.2.1 Type I
  • 9.4.2.2 Type II
  • 9.4.3 Active Pharmaceutical Ingredient Sales, Revenue, Price of Albemarle (2015 and 2016)
  • 9.5 Sun Pharmaceutical Industries
  • 9.5.1 Company Basic Information,Manufacturing Base and Competitors
  • 9.5.2 Active Pharmaceutical Ingredient Product Type and Technology
  • 9.5.2.1 Type I
  • 9.5.2.2 Type II
  • 9.5.3 Active Pharmaceutical Ingredient Sales, Revenue, Price of Sun Pharmaceutical Industries (2015 and 2016)
  • 9.6 Mylan
  • 9.6.1 Company Basic Information,Manufacturing Base and Competitors
  • 9.6.2 Active Pharmaceutical Ingredient Product Type and Technology
  • 9.6.2.1 Type I
  • 9.6.2.2 Type II
  • 9.6.3 Active Pharmaceutical Ingredient Sales, Revenue, Price of Mylan (2015 and 2016)
  • 9.7 Dr. Reddy’s Laboratories
  • 9.7.1 Company Basic Information,Manufacturing Base and Competitors
  • 9.7.2 Active Pharmaceutical Ingredient Product Type and Technology
  • 9.7.2.1 Type I
  • 9.7.2.2 Type II
  • 9.7.3 Active Pharmaceutical Ingredient Sales, Revenue, Price of Dr. Reddy’s Laboratories (2015 and 2016)
  • 9.8 Sigma-Aldrich
  • 9.8.1 Company Basic Information,Manufacturing Base and Competitors
  • 9.8.2 Active Pharmaceutical Ingredient Product Type and Technology
  • 9.8.2.1 Type I
  • 9.8.2.2 Type II
  • 9.8.3 Active Pharmaceutical Ingredient Sales, Revenue, Price of Sigma-Aldrich (2015 and 2016)
  • 9.9 Allergan
  • 9.9.1 Company Basic Information,Manufacturing Base and Competitors
  • 9.9.2 Active Pharmaceutical Ingredient Product Type and Technology
  • 9.9.2.1 Type I
  • 9.9.2.2 Type II
  • 9.9.3 Active Pharmaceutical Ingredient Sales, Revenue, Price of Allergan (2015 and 2016)
  • 9.10 Boehringer Ingelheim
  • 9.10.1 Company Basic Information,Manufacturing Base and Competitors
  • 9.10.2 Active Pharmaceutical Ingredient Product Type and Technology
  • 9.10.2.1 Type I
  • 9.10.2.2 Type II
  • 9.10.3 Active Pharmaceutical Ingredient Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)
  • 10 Active Pharmaceutical Ingredient Technology and Development Trend
  • 10.1 Active Pharmaceutical Ingredient Technology Analysis
  • 10.2 Active Pharmaceutical Ingredient Technology Development Trend
  • 11 Research Findings and Conclusion

Please select a license type

Share

Related Products

QYResearchEurope Active Pharmaceutical Ingredient Sales Market Report 2020 Product ThumbnailEurope Active Pharmaceutical Ingredient Sales Market Report 2020 , Industry ReportProduct #: 497709
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved